<?xml version='1.0' encoding='UTF-8'?><rdsi.pacelf.phase3:document xmlns:rdsi.pacelf.phase3='http://www.example.com' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' ><PacELF_ID>474</PacELF_ID><type>Electronic</type><category>Scientific Papers</category><title>Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes</title><description>Background WHO has targeted lymphatic filariasis for elimination. Studies of vector-parasite relations of Wuchereria bancrofti suggest that a reduction in the microfilarial reservoir by mass chemotherapy may interrupt transmission and thereby eliminate infection. However, no field data exist on the impact of chemotherapy alone on vector efficiency and transmission intensity of W bancrofti. We compared the impact of an annual community-wide single-dose treatment with diethylcarbamazine alone or with ivermectin on rate and intensity of microfilaraemia, and transmission intensity in an area of Papua New Guinea endemic for intense W bancrofti transmission.</description><year>1998</year><authors>Bockarie, M.J., Alexander, N.D.E., Hyun, P., Dimber, Z., Bockarie, F., Ibam, E., Alpers, M.P., Kazura, J.W.</authors><journal>Lancet</journal><volume-issue>351(9097)</volume-issue><pages>162-168</pages><work_location>Papua New Guinea</work_location><language>English</language><access_rights>Restricted</access_rights><pdf_file_name>Papua New Guinea/Bockarie et al 1998 Lancet Randomized trial of DEC vs DEC+ivermectin LF PNG.pdf</pdf_file_name><decade>1990</decade></rdsi.pacelf.phase3:document>